Abstract
There is great diversity in in vitro fertilization (IVF) funding and reimbursement policies and practice throughout Europe and the rest of the world. While many existing reimbursement and regulatory frameworks address safety and legal concerns, economic factors also assume a central role. However, there are several problems with the evidence that is available on the economics of IVF. This suggests there is a need for more robust cost-effectiveness studies. It also indicates the need for alternative rationales to justify the reimbursement of IVF, which might more fully account for the social, political, ethical, and philosophical considerations embedded in notions of infertility and technology-driven reproductive treatments. The merits and limitations of five alternative rationales are discussed. The review suggests that while no existing single rationale provides a complete framework with which to support funding decisions, taken together they provide guideposts which signal important issues for consideration and highlight where further research, action, and debate are needed.
Similar content being viewed by others
Notes
Other ART treatments include intra cyto-plasmic sperm injection (ICSI), frozen embryo replacement (FER), egg donation (ED), in vitro maturation (IVM), and preimplantation genetic diagnosis/screening (PGD/PGS).
WTP places the relative benefits of a treatment in monetary, rather than health-related, terms.
There may be other, ethical, reasons for excluding ‘socially infertile’ women from IVF treatment. For example, Sect. 13(5) of the UK Human Fertilization and Embryology Act 1990 states that: “a woman shall not be provided with treatment services unless account has been taken of the welfare of the child who may be born as a result of the treatment (including the need of that child for a father), and of any other child who may be affected by the birth”.
It is not clear whether the survey distinguished between the cost of three successful cycles as compared to the cost of a successful hip replacement or simply the unit cost. If only the unit cost was used, the ‘real’ cost of IVF was probably seriously under-estimated as compared to the cost of a hip replacement.
FINRRAGE is opposed to genetic research which, they argue, promotes the commodification of life and a ‘new’ eugenics seeking to create perfect ‘designer’ children. It is, however, beyond the scope of this article to discuss the arguments for and against genetic research.
The main policies that have been employed by governments to address population ageing can be divided into two groups: 1) demographic policies, specifically immigration and family support measures aimed at increasing fertility and 2) welfare-related policies, such as increasing labour force participation, raising the age of retirement, and reducing public pension benefits [4].
The low fertility trap entails a country’s TFR falling to less than 1.5, causing a relatively rapid decline in the birth rate, as the small cohorts born in many European countries since the mid 1980 s reach reproductive age.
References
Adashi, E. Y., et al. (2000). Public perception on infertility and its treatment: An international survey. The Bertarelli Foundation Scientific Board. Human Reproduction (Oxford, England), 15(2), 330–334. doi:10.1093/humrep/15.2.330.
Andersen, A. N., Gianaroli, L. R., Felberbaum, J., Mouzon, J., & Nygren, K. G. (2006). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England). doi:10.1093/humrep/del075.
Blyth, E. F. A. (2005). Reproductive tourism: A price worth paying for reproductive autonomy? Critical Social Policy, 25(1), 91–114. doi:10.1177/0261018305048969.
Bongaarts, J. (2004). Population aging and rising cost of public pensions. Population and Development Review, 30(1), 1–23. doi:10.1111/j.1728-4457.2004.00001.x.
Britt, E. C. (2001). Conceiving normalcy: Rhetoric, law, and the double binds of infertility. Rhetoric, culture, and social critique (Vol. xi, p. 206). Tuscaloosa: University of Alabama Press.
Buckett, W., & Bentick, B. (1997). The epidemiology of infertility in a rural population. Acta Obstetricia et Gynecologica Scandinavica, 76(3), 233–237. doi:10.3109/00016349709048147.
Burrell, R. (2005). Assisted reproduction in the nordic countries. A comparative study of policies and regulation. Nordic Committee on Bioethics. Published on-line at: http://www.ncbio.org/NcBioBurrell.pdf.
Caldwell, J., Caldwell, P., & McDonald, P. (2002). Policy responses to low fertility and its consequences: A global survey. Journal of Population Research, 19(1), 1–24.
Campagne, D. M. (2006). Should fertilization treatment start with reducing stress? Human Reproduction, 21(7), 1651–1658. Jul.
Collins, J. (2002). An international survey of the health economics of IVF and ICSI. Human Reproduction Update, 8(3), 265–277. doi:10.1093/humupd/8.3.265.
Collins, J. A., & Rowe, T. C. (1989). Age of the female partner is a prognostic factor in prolonged unexplained infertility: A multicenter study. Fertility and Sterility, 52(1), 15–20.
Culyer, A. J. (2001). Equity—some theory and its policy implications. Journal of Medical Ethics, 27(4), 275–283. doi:10.1136/jme.27.4.275.
Daniels, N. (1985). Just health care. Cambridge: Cambridge University Press.
Devlin, N., & Parkin, D. (2003). Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies. Human Fertility (Cambridge, England), 6(2, Suppl), S2–S6. doi:10.1080/1464770312331369153.
Egnatz, D. G., et al. (1980). DBCP and testicular effects in chemical workers: An epidemiological survey in Midland, Michigan. Journal of Occupational Medicine, 22(11), 727–732.
Eijkemans, M. J., Polinder, S., Mulders, A. G., Laven, J. S., Habbema, J. D., & Fauser, B. C. (2005). Individualized cost-effectiveness conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Human Reproduction (Oxford, England), 20(10), 2830–2837. doi:10.1093/humrep/dei164. Epub 2005 July.
European Society of Human Reproduction, Embryology Task Force on Ethics, Law. (2003). Ethical issues related to multiple pregnancies in medically assisted procreation. Human Reproduction (Oxford, England), 18(9), 1976–1979. doi:10.1093/humrep/deg357.
Garceau, L., Henderson, J., Davis, L. J., Petrou, S., Henderson, L. R., McVeigh, E., et al. (2002). Economic implications of assisted reproductive techniques: A systematic review. Human Reproduction (Oxford, England), 17(12), 3090–3109. doi:10.1093/humrep/17.12.3090.
Gauthier, A., & Hatzius, J. (1997). Family benefits and fertility: An econometric analysis. Population Studies, 51(3), 295–306. doi:10.1080/0032472031000150066.
Giacomini, M., Hurley, J., & Stoddart, G. (2000). The many meanings of deinsuring a health service: The case of in vitro fertilization in Ontario. Social Science & Medicine, 50(10), 1485–1500.
Gissler, M., Silverio, M. M., & Hemminki, E. (1995). In-vitro fertilization pregnancies and prenatal health in Finland 1991–1993. Human Reproduction, 10, 1856–1861.
Gissler, M., & Tiitinen, A. (2001). IVF treatments and their outcomes in Finland in the 1990s. Acta Obstetricia et Gynecologica Scandinavica, 80(10), 937–944.
Goldfarb, J. N., Austin, C., Lisbona, H., Peskin, B., & Clapp, M. (1996). Cost-effectiveness of in vitro fertilization. Obstetrics and Gynecology, 87, 18–21.
Grant, J., Hoorens, S., Gallo, F., & Cave, J. (2006). Should ART be part of a population policy mix? a preliminary assessment of the demographic and economic impact of assisted reproductive technologies. Europe: RAND.
Gunnell, D. J., & Ewings, P. (1994). Infertility prevalence, needs assessment and purchasing. Journal of Public Health Medicine, 16, 29–36.
Habbema, J. D., et al. (2004). Towards less confusing terminology in reproductive medicine: A proposal. Fertility and Sterility, 82(1), 36–40. doi:10.1016/j.fertnstert.2004.04.024.
Hervey, T. K. (1998). Buy baby: The European Union and regulation of human reproduction. Oxford Journal of Legal Studies, 18, 207–233. doi:10.1093/ojls/18.2.207.
Hughes, E. G., & Giacomini, M. (2001). Funding in vitro fertilization treatment for persistent subfertility: The pain and the politics. Fertility and Sterility, 76(3), 431–442. doi:10.1016/S0015-0282(01)01928-8.
Hull, M. G., et al. (1985). Population study of causes, treatment, and outcome of infertility. British Medical Journal (Clinical Research Ed.), 291(6510), 1693–1697.
Human Fertilization & Embryology Authority. (2006). Figures for treatment of single women and lesbian couples 2000–2005. http://www.hfea.gov.uk/cps/HFEA/files/Figures_for_treatment_of_single_women_and_lesbian_couples_2000-2005.pdf.
Iowa. Supreme Court. (1988). Witcraft v. Sundstrand Health and Disability Group Benefit Plan. West's North Western Reporter, 420, 785–790.
Jain, T., & Hornstein, M. D. (2005). Disparities in access to infertility services in a state with mandated insurance coverage. Fertility and Sterility, 84(1), 221–223. doi:10.1016/j.fertnstert.2005.01.118.
Jose-Miller, A. B., Boyden, J. W., & Frey, K. A. (2007). Infertility. American Family Physician, 75(6), 849–856.
Katz, P., Nachtigall, R., & Showstack, J. (2002). The economic impact of the assisted reproductive technologies. Nature Cell Biology and Nature Medicine. Published on-line at: www.nature.com/fertility.
Kennedy, R., et al. (2006). Implementation of the NICE guideline—recommendations from the British Fertility Society for national criteria for NHS funding of assisted conception. Human Fertility (Cambridge, England), 9(3), 181–189. doi:10.1080/14647270600908411.
Klein, R. (2008). From test-tube women to bodies without women. Women’s Studies International Forum, 31, 157–175. doi:10.1016/j.wsif.2008.04.006.
Klemetti, R., Gissler, M., & Hemminki, E. (2004). Equity in the use of IVF in Finland in the late 1990s. Scandinavian Journal of Public Health, 32(3), 203–209. doi:10.1080/14034940310018444.
Ledger, W. G., Hoorens, F., Ziebe, S., & Connolly, M. (2006). Abstracts of the 22nd annual meeting of the ESHRE, Prague, Czech Republic, 18–21 June 2006. present discounted value of children born using IVF compared with naturally conceived children: A simplified UK calculation. Human reproduction (Oxford, England), 21(Supplement 1), i74–i75.
Legro, R. S., Shakleford, D. P., Moessner, J. M., Gnatuk, C. L., & Dodson, W. C. (1997). ART in women 40 and over. Is it worth it? The Journal of Reproductive Medicine, 42(2), 76–82.
Ludwig, A. K., Sutcliffe, A. G., Diedrich, K., & Ludwig, M. (2006). Post-neonatal health and development of children born after assisted reproduction: A systematic review of controlled studies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127(1), 3–25. doi:10.1016/j.ejogrb.2006.02.009.
McDonald, P. (2006). Low fertility and the state: The efficacy of policy. Population and Development Review, 32(3), 485–510. doi:10.1111/j.1728-4457.2006.00134.x.
McMillan, J. (2001). Allocating fertility services by medical need. Human Fertility (Cambridge, England), 4(1), 11–13. doi:10.1080/1464727012000199191.
McMillan, J. R. (2003). NICE, the draft fertility guideline and dodging the big question. Journal of Medical Ethics, 29(6), 313–314. doi:10.1136/jme.29.6.313.
Metherell, M. (2005). Lib women demand end to IVF cuts. The sydney morning herald. http://www.smh.com.au/news/National/Lib-women-demand-end-to-IVF-cuts/2005/04/27/1114462103506.html. Accessed 15 May 2007.
Millns, S. (2002). Reproducing inequalities: Assisted conception and the challenge of legal pluralism. Journal of Social Welfare and Family Law, 24, 19–36. doi:10.1080/09649060110112668.
Mladovsky, P. (2006). ART treatment in the EU: IVF and reproductive tourism. Euro Observer, 8(4), 5.
Mol, B. J., Bonsel, G. J., Collins, J. A., Wiegerinck, M., Van Der Veen, F., & Bossuyt, P. M. (2001). Cost-effectiveness of in vitro fertilization and embryo transfer. Fertility and Sterility, 73, 748–754. doi:10.1016/S0015-0282(99)00610-X.
National Collaborating Centre for Women’s, Children’s Health. (2004). Fertility assessment and treatment for people with fertility problems. Clinical guideline commissioned by NICE. London: RCOG Press.
Neumann, P. J. (1997). Should health insurance cover IVF? issues and options. Journal of Health Politics, Policy and Law, 22(5), 1215–1239.
Neumann, P. J., Gharib, S. D., & Weinstein, M. C. (1994). The cost of a successful delivery with in-vitro fertilization. NEJM, 331, 239–243.
Nygren, K. G., & Andersen, A. N. (2001). Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England), 16(2), 384–391. doi:10.1093/humrep/16.2.384.
Oberlander, J., Marmor, T., & Jacobs, L. (2001). Rationing medical care: Rhetoric and reality in the Oregon Health Plan. Canadian Medical Association Journal, 164(11), 583–587.
Pennings, G. (2004). Legal harmonization and reproductive tourism in Europe. Human Reproduction (Oxford, England), 19(12), 2689–2694. doi:10.1093/humrep/deh486.
Population Commission United Nations. (1996). Reproductive rights and reproductive health: A concise report. POP/623, Geneva: United Nations.
Rickard, M. (2001). Is it medically legitimate to provide assisted reproductive treatments to fertile lesbians and single women? Research paper No. 23 2000–01. Australia: Department of the Parliamentary Library.
Slutsky, M., Levin, J. L., & Levy, B. S. (1999). Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. International Journal of Occupational and Environmental Health, 5(2), 116–122.
Smajdor, A. (2007). State-funded IVF will make us rich… or will it? Journal of Medical Ethics, 33(8), 468–469.
Smith, R. (2002). In search of “non-disease”. BMJ (Clinical Research Ed), 324(7342), 883–885. doi:10.1136/bmj.324.7342.883.
Sorenson, C. (2006). IVF/ART funding and reimbursement. Euro Observer, 8(4), 6–7.
Spar, D. (2005). Reproductive tourism and the regulatory map. The New England Journal of Medicine, 352(6), 531–533. doi:10.1056/NEJMp048295.
Suchartwatnachai, C., Wongkularb, A., Srisombut, C., Choktanasiri, W., Chinsomboon, S., & Rojanasakul, A. (2000). Cost-effectiveness of IVF in women 38 years and older. International Journal of Gynecology and Obstetrics: The Official Organ of the International Federation of Gynecology and Obstetrics, 69, 143–148. doi:10.1016/S0020-7292(99)00215-5.
Sunde, A. (2007). Europe’s declining population and the contribution of ART. Pharmaceuticals. Policy and Law, 9, 79–89.
Surveillance, I. F. F. S. (2004). A survey of the current status of assisted reproductive technology procedures around the world. Fertility and Sterility, 81(4), S9–S54.
Sykes, D., Henk, J. O., Palmer, S. J., & van Loon, J. (2001). The cost-effectiveness of IVF in the UK: A comparison of three gonadotrophin treatments. Human Reproduction, 16(12), 2557–2562.
Tannsjo, T. (2007). Who should bear the cost of IVF? In search of a just solution. Reproductive Biomedicine Online, 14(Suppl 1), 149–157.
Templeton, A., Fraser, C., & Thompson, B. (1990). The epidemiology of infertility in Aberdeen. BMJ (Clinical Research Ed.), 301(6744), 148–152.
Throsby, K. (2004). When IVF fails: Feminism, infertility and the negotiation of normality (p. 223). Basingstoke: Palgrave Macmillan.
United Nations. (1948). Universal Declaration of Human Rights. Adopted and proclaimed by General Assembly resolution 217 A (III) of 10 December 1948.
Verhaak, C. M., Smeenk, J. M., Evers, A. W., Kremer, J. A., Kraaimaat, F. W., & Braat, D. D. (2007). Women’s emotional adjustment to IVF: A systematic review of 25 years of research. Human Reproduction Update, 13(1), 27–36. doi:10.1093/humupd/dml040.
Warnock, M. (2002). Making babies : Is there a right to have children? (Vol. vi, p. 120). New York: Oxford University Press.
World Bank. (2007). World Development Indicators (WDI) database. Published on-line at: http://go.worldbank.org/SI5SSGAVZ0.
Acknowledgments
The authors are grateful to the anonymous referees for their helpful comments and suggestions and to Elias Mossialos and Harald Schmidt for their input into certain sections of the article. Part of this article is based on research undertaken for a project funded by the European Commission, DG Employment, Social Affairs and Equal Opportunities, on health status and living conditions in the EU, Contract No. VC/2005/0781. All the views expressed are the authors’ own.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mladovsky, P., Sorenson, C. Public Financing of IVF: A Review of Policy Rationales. Health Care Anal 18, 113–128 (2010). https://doi.org/10.1007/s10728-009-0114-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10728-009-0114-3